Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Time-to-Contact Analysis of Gait Stability in the Swing Phase of Walking in People With Multiple Sclerosis.
Addressing the regulatory and scientific challenges in multiple sclerosis - a statement from the EU regulators.
Resource utilization, costs and treatment patterns of switching and discontinuing treatment of MS patients with high relapse activity.
Current and Emerging Therapies for Multiple Sclerosis.
Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.
Correction: Selective Blockade of CD28-Mediated T Cell Costimulation Protects Rhesus Monkeys against Acute Fatal Experimental Autoimmune Encephalomyelitis.
Alarmin' Immunologists: IL-33 as a Putative Target for Modulating T Cell-Dependent Responses.
Outcomes After Early Administration of Plasma Exchange in Pediatric Central Nervous System Inflammatory Demyelination.
Microvesicles in the brain: Biomarker, messenger or mediator?
An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations.
Caregiving in multiple sclerosis.
Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation.
Cardiovascular effects of fingolimod: Relevance, detection and approach.
Changes of Synaptic Plasticity in Multiple Sclerosis.
[The treatment by expanded ex vivo autologous regulatory T-cells CD4+CD25+FoxP3+CD127low restores the balance of immune system in patients with remitting-relapsing multiple sclerosis].
Relating multi-sequence longitudinal intensity profiles and clinical covariates in incident multiple sclerosis lesions.
Changes in normal appearing spinal cord in multiple sclerosis: another brick in the wall.
Plasma Exchange and Immunoadsorption in Pediatric Inflammatory Optic Neuropathy Resistant to Corticosteroid Therapy: Four French Cases.
Prescriptive Oriented Drug Analysis of Multiple Sclerosis Disease by LC-UV in Whole Human Blood.
Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
The roles of extracellular related-kinases 1 and 2 signaling in CNS myelination.
Dicer and microRNA expression in multiple sclerosis and response to interferon therapy.
Role of ERK1/2 MAPK Signaling in the Maintenance of Myelin and Axonal Integrity in the Adult CNS.
The magnetic resonance imaging 'rule of five': predicting the occurrence of relapse.
Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
619
620
621
622
623
624
625
626
627
…
next ›
last »